Videos

7 Diagnostic and Genomic Stocks Storming Into October

COVID-19 has created an Apollo Mission status for advanced medical technologies and smart investors are profiting.

Articles You May Like

Activist Elliott settles for a new director at Sensata. These next steps may help boost shares
Stagflation Stocks to Sell: 3 Consumer Brands on Very Thin Ice
So Much for That: Microsoft Just Blew Up Its Gaming Strategy
Warren Buffet’s Blunders: 3 Investments Even the Oracle Regrets
Tech Wreck Trio: 3 Stocks to Eject Before They Short-Circuit Your Portfolio